Clinical Trials

Can Selective Gene Inactivation Explain Disease Variability?
Research & Development Can Selective Gene Inactivation Explain Disease Variability?

Traditionally, it is believed that each cell contains two copies of each gene, one from each parent, playing equal parts in cellular functions. This new study challenges that notion by revealing that some cells exhibit a bias and inactivate one parental gene copy over the other. This phenomenon,

New Non-Invasive Blood Test Revolutionizes Endometriosis Diagnosis
Research & Development New Non-Invasive Blood Test Revolutionizes Endometriosis Diagnosis

Endometriosis, a chronic and often debilitating condition affecting approximately 190 million women and teenage girls globally, has traditionally been diagnosed through a lengthy and invasive process. For years, women have had to endure intrusive procedures and lengthy waits before receiving a

Can Tumor Organoids From Blood Samples Transform Breast Cancer Treatment?
Research & Development Can Tumor Organoids From Blood Samples Transform Breast Cancer Treatment?

A significant breakthrough by researchers from the German Cancer Research Center (DKFZ), Heidelberg Stem Cell Institute (HI-STEM), and NCT Heidelberg in addressing breast cancer metastasis has the potential to revolutionize treatment approaches. Metastases to vital organs like the liver, lungs, or

Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279
Research & Development Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279

Psoriasis, often misunderstood as merely a skin condition, is a complex immune-mediated disease impacting around 125 million individuals globally. This systemic condition demands comprehensive treatment strategies that go beyond addressing superficial skin symptoms. Dr. Graham Heap, Vice President

Can Large-Scale Genomic Profiling Revolutionize Cancer Treatment?
Tech & Innovation Can Large-Scale Genomic Profiling Revolutionize Cancer Treatment?

Recent advancements in genomic analysis have demonstrated significant potential to improve outcomes for patients across a wide spectrum of cancer types. A large-scale study conducted by researchers from Genentech and Stanford University analyzed nearly 80,000 U.S. cancer patients to uncover 776

Is Clozapine Safe for Schizophrenia Patients Regarding Blood Cancer Risks?
Research & Development Is Clozapine Safe for Schizophrenia Patients Regarding Blood Cancer Risks?

The notable effectiveness of clozapine in treating schizophrenia has placed it as the sole FDA-approved option for patients resistant to other treatments. However, despite its advantages, concerns have lingered due to studies suggesting a potential association between clozapine use and an increased

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later